Wei‐Chih Su

1.2k total citations
79 papers, 790 citations indexed

About

Wei‐Chih Su is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Chih Su has authored 79 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 30 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Chih Su's work include Colorectal Cancer Surgical Treatments (25 papers), Colorectal Cancer Treatments and Studies (24 papers) and Gastric Cancer Management and Outcomes (21 papers). Wei‐Chih Su is often cited by papers focused on Colorectal Cancer Surgical Treatments (25 papers), Colorectal Cancer Treatments and Studies (24 papers) and Gastric Cancer Management and Outcomes (21 papers). Wei‐Chih Su collaborates with scholars based in Taiwan, United States and China. Wei‐Chih Su's co-authors include Jaw‐Yuan Wang, Tsung‐Kun Chang, Ching‐Wen Huang, Yung‐Sung Yeh, Cheng‐Jen Ma, Hsiang‐Lin Tsai, Yen‐Cheng Chen, Po-Jung Chen, Hsiang‐Lin Tsai and Chun‐Ming Huang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wei‐Chih Su

75 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Chih Su Taiwan 15 370 272 197 161 99 79 790
Xu Guo China 18 333 0.9× 207 0.8× 312 1.6× 207 1.3× 97 1.0× 48 886
Austin R. Dosch United States 13 294 0.8× 126 0.5× 188 1.0× 107 0.7× 71 0.7× 30 659
Liqun Jia China 14 155 0.4× 122 0.4× 305 1.5× 149 0.9× 76 0.8× 68 717
Yonghua Shen China 15 214 0.6× 265 1.0× 354 1.8× 212 1.3× 89 0.9× 40 766
Nobuyasu Takada Japan 17 163 0.4× 381 1.4× 235 1.2× 300 1.9× 53 0.5× 48 796
Shingo Tsujinaka Japan 20 615 1.7× 538 2.0× 214 1.1× 255 1.6× 83 0.8× 75 1.2k
Guang‐wei Xu China 16 151 0.4× 485 1.8× 284 1.4× 326 2.0× 107 1.1× 31 1.0k
H Taniguchi Japan 13 175 0.5× 156 0.6× 108 0.5× 175 1.1× 36 0.4× 44 585
Tian‐Quan Han China 14 296 0.8× 465 1.7× 169 0.9× 287 1.8× 137 1.4× 28 743
Eduardo E. Montalvo‐Javé Mexico 13 128 0.3× 402 1.5× 178 0.9× 114 0.7× 90 0.9× 61 843

Countries citing papers authored by Wei‐Chih Su

Since Specialization
Citations

This map shows the geographic impact of Wei‐Chih Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chih Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chih Su more than expected).

Fields of papers citing papers by Wei‐Chih Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chih Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chih Su. The network helps show where Wei‐Chih Su may publish in the future.

Co-authorship network of co-authors of Wei‐Chih Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chih Su. A scholar is included among the top collaborators of Wei‐Chih Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chih Su. Wei‐Chih Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tsai, Hsiang‐Lin, et al.. (2024). Is ypTNM staging a comparable predictor as pTNM staging for survival in non-metastatic rectal cancer after preoperative chemoradiation therapy?. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 0(0). 1–10. 1 indexed citations
3.
Chang, Yu‐Tang, Hsiang‐Lin Tsai, Yen‐Cheng Chen, et al.. (2023). Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy. Journal of Oncology. 2023. 1–9. 3 indexed citations
4.
Chen, Yen‐Cheng, Ching‐Wen Huang, Tsung‐Kun Chang, et al.. (2023). Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis. World Journal of Surgical Oncology. 21(1). 378–378. 4 indexed citations
6.
Huang, Chun‐Ming, Hsiang‐Lin Tsai, Yen‐Cheng Chen, et al.. (2022). Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review. Frontiers in Oncology. 12. 889658–889658. 7 indexed citations
7.
Su, Wei‐Chih, Fang‐Ming Chen, Hsiang‐Lin Tsai, et al.. (2020). Effects of Good Pain Management (GPM) ward program on patterns of care and pain control in patients with cancer pain in Taiwan. Supportive Care in Cancer. 29(4). 1903–1911. 4 indexed citations
8.
Su, Wei‐Chih, Tsung‐Kun Chang, Cheng‐Jen Ma, et al.. (2020). Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study. World Journal of Surgical Oncology. 18(1). 308–308. 8 indexed citations
11.
Yeh, Yung‐Sung, Yi‐Ting Chen, Hsiang-Lin Tsai, et al.. (2019). Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy. Pathology & Oncology Research. 26(2). 1105–1116. 14 indexed citations
13.
Su, Wei‐Chih, Hsiang‐Lin Tsai, Yung‐Sung Yeh, et al.. (2018). Combined computed tomography-measured tumor density and RECIST for evaluating neoadjuvant therapy in locally advanced gastrointestinal stromal tumors. Translational Cancer Research. 7(3). 634–644. 1 indexed citations
14.
Chen, Brian Po‐Jung, Ching‐Wen Huang, Hsiang‐Lin Tsai, et al.. (2018). Robotic-assisted total mesorectal excision in low-lying rectal cancer. Mini-invasive Surgery. 2018. 1 indexed citations
16.
Su, Wei‐Chih, Hsiang‐Lin Tsai, Chun‐Chieh Wu, et al.. (2018). Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer. World Journal of Surgical Oncology. 16(1). 21–21. 7 indexed citations
17.
Chang, Tsung‐Kun, Hsiang‐Lin Tsai, Wei‐Chih Su, et al.. (2018). The clincopathological variables to differentiate the nature of isolated pulmonary nodules in patients who received curative surgery for colorectal cancer. Asian Journal of Surgery. 42(2). 425–432. 5 indexed citations
18.
Han, Ming‐Lun, Yao‐Ming Wu, Kao‐Lang Liu, Wei‐Chih Su, & Hsiu–Po Wang. (2008). Tension pneumothorax after an ERCP in a patient with hepatic hydrothorax and sealed-off perforated duodenal ulcer. Gastrointestinal Endoscopy. 68(4). 771–772. 4 indexed citations
19.
Wang, Hsiu‐Po & Wei‐Chih Su. (2006). Veiled Right Kidney Sign in a Patient with Valentino's Syndrome. New England Journal of Medicine. 354(10). e9–e9. 13 indexed citations
20.
Lee, Ching‐Tai, Shih‐Pei Huang, Tsu‐Yao Cheng, et al.. (2006). Factors associated with myocardial infarction after emergency endoscopy for upper gastrointestinal bleeding in high-risk patients: a prospective observational study. The American Journal of Emergency Medicine. 25(1). 49–52. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026